Home/Ambulero/Robert L. Buchanan

RL

Robert L. Buchanan

Chief Executive Officer

Therapeutic Areas

Vascular Disease Critical Limb Ischemia Non-healing Wounds

Ambulero Pipeline

Drug	Indication	Phase
Supercharged MSCs (E-selectin)	Rare Vascular Ischemia	Pre-clinical
AAV Gene Therapy (E-selectin)	Rare Vascular Ischemia	Pre-clinical

Leadership Team at Ambulero

Carlton Anderson

Chief Operating Officer

Omaida Caridad Velazquez

Chief Medical Officer

Chief Scientific Officer

View full Ambulero profile